DK0423980T3 - Stamcellefaktor - Google Patents

Stamcellefaktor

Info

Publication number
DK0423980T3
DK0423980T3 DK90310899T DK90310899T DK0423980T3 DK 0423980 T3 DK0423980 T3 DK 0423980T3 DK 90310899 T DK90310899 T DK 90310899T DK 90310899 T DK90310899 T DK 90310899T DK 0423980 T3 DK0423980 T3 DK 0423980T3
Authority
DK
Denmark
Prior art keywords
scf
dna sequence
stem cell
cell factor
biological activity
Prior art date
Application number
DK90310899T
Other languages
Danish (da)
English (en)
Inventor
Krisztina M Zsebo
Sidney Vaughn Suggs
Robert A Bosselman
Francis Hall Martin
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1990/005548 external-priority patent/WO1991005795A1/en
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0423980T3 publication Critical patent/DK0423980T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
DK90310899T 1989-10-16 1990-10-04 Stamcellefaktor DK0423980T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US42238389A 1989-10-16 1989-10-16
US53719890A 1990-06-11 1990-06-11
US57361690A 1990-08-24 1990-08-24
PCT/US1990/005548 WO1991005795A1 (en) 1989-10-16 1990-09-28 Stem cell factor
US58970190A 1990-10-01 1990-10-01

Publications (1)

Publication Number Publication Date
DK0423980T3 true DK0423980T3 (da) 2000-10-09

Family

ID=27503703

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90310899T DK0423980T3 (da) 1989-10-16 1990-10-04 Stamcellefaktor

Country Status (11)

Country Link
US (3) US6218148B1 (xx)
EP (4) EP0992579B1 (xx)
CN (2) CN1289526C (xx)
AT (2) ATE403713T1 (xx)
CZ (3) CZ286303B6 (xx)
DE (2) DE69034258D1 (xx)
DK (1) DK0423980T3 (xx)
GR (1) GR3034559T3 (xx)
HK (1) HK1010397A1 (xx)
SG (2) SG43009A1 (xx)
SK (2) SK98199A3 (xx)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759215B1 (en) * 1989-10-16 2004-07-06 Amgen Inc. Method of preparing human stem cell factor polypeptide
WO1992000376A1 (en) * 1990-06-25 1992-01-09 Immunex Corporation Mast cell growth factor
US20050276784A1 (en) * 1990-08-27 2005-12-15 Solan-Kettering Institute For Cancer Research Ligand for the c-kit receptor and methods of use thereof
US5767074A (en) * 1990-08-27 1998-06-16 Sloan-Kettering Institute For Cancer Research Compositions of soluble C-kit ligand and hematopoietic factors
US20030125519A1 (en) 1990-08-27 2003-07-03 Peter Besmer Ligand for the c-kit receptor and methods of use thereof
DE4224050A1 (de) * 1991-07-31 1993-02-04 Hoffmann La Roche Loesliche kit-liganden
US6001803A (en) * 1992-04-23 1999-12-14 Sloan-Kettering Institute For Cancer Research Composition of c-kit ligand, GM-CSF, and TNF-α and method of use
WO1993021936A1 (en) * 1992-04-23 1993-11-11 Sloan-Kettering Institute For Cancer Research LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
US6288030B1 (en) 1993-12-22 2001-09-11 Amgen Inc. Stem cell factor formulations and methods
US5525708A (en) * 1994-03-28 1996-06-11 Cytomed, Inc. Covalent dimer of kit ligand
IL115825A (en) 1994-11-04 2006-07-05 Serono Lab Human stem cell factor (scf) protein, dna sequences coding for this protein and pharmaceutical compositions comprising such a protein
US5824789A (en) * 1995-06-07 1998-10-20 Systemix, Inc. Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof
US5731284A (en) * 1995-09-28 1998-03-24 Amgen Inc. Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
US6184200B1 (en) 1995-09-28 2001-02-06 Amgen Inc. Truncated glial cell line-derived neurotrophic factor
SI9620116A (sl) 1995-10-04 1999-08-31 Immunex Corporation Stimulatorni faktor dendritičnih celic
US5641750A (en) * 1995-11-29 1997-06-24 Amgen Inc. Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
US5641749A (en) * 1995-11-29 1997-06-24 Amgen Inc. Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product
US5741778A (en) * 1996-03-19 1998-04-21 Amgen Inc. Method for treating Huntington's disease using glial cell line-derived neurotrophic factor (GDNF) protein product
US5885962A (en) * 1996-04-05 1999-03-23 Amgen Inc. Stem cell factor analog compositions and method
US6495365B1 (en) 1996-08-13 2002-12-17 Fujisawa Pharmaceutical Co., Ltd. Hematopoietic stem cell proliferating agents
US6967092B1 (en) 1996-10-25 2005-11-22 Mc Kearn John P Multi-functional chimeric hematopoietic receptor agonists
US5969105A (en) * 1996-10-25 1999-10-19 Feng; Yiqing Stem cell factor receptor agonists
JPH10158188A (ja) * 1996-11-29 1998-06-16 Senju Pharmaceut Co Ltd 角膜治療用組成物
JP2003518929A (ja) * 1999-12-23 2003-06-17 ユニヴェルシテ・ドゥ・ジュネーブ 基底側部選別シグナル、およびその阻害物質
US7767197B2 (en) 2000-06-22 2010-08-03 Endo Pharmaceuticals Colorado LLC Delivery vehicle composition and methods for delivering antigens and other drugs
BR0111948A (pt) * 2000-06-26 2004-08-24 Rxkinetix Inc Composição para entrega de fator de crescimento hematopoiético
CA2449978A1 (en) * 2001-06-15 2002-12-27 Johns Hopkins Singapore Pte Ltd Biofunctional fibers
WO2003039232A2 (en) * 2001-10-26 2003-05-15 Large Scale Biology Corporation Endothelial cell derived hemotopoietic growth factor
CA2469135A1 (en) * 2001-11-27 2003-06-05 Nexyte Ab Production of eukaryotic proteins and nucleic acid molecules in c. elegans
AU2003208524A1 (en) 2003-02-14 2004-09-06 Istituto Superiore Di Sanita Stem cell factor for preventing chemotherapy-induced depletion of blood cells
CN100345971C (zh) * 2003-07-14 2007-10-31 第二军医大学免疫学研究所 重组人干细胞因子的原核表达载体、工程菌及制备方法
WO2005058937A2 (en) 2003-12-12 2005-06-30 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
US7943308B2 (en) * 2004-06-23 2011-05-17 Epigenomics Ag Methods and nucleic acids for the detection of metastasis of colon cell proliferative disorders
WO2006005360A1 (en) * 2004-07-12 2006-01-19 Sorin Group Italia S.R.L. Devices and methods for growing human cells
AU2005306894B2 (en) 2004-11-05 2011-11-24 Northwestern University Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders
WO2006138181A2 (en) 2005-06-14 2006-12-28 Amgen Inc. Self-buffering protein formulations
US7790679B2 (en) * 2005-08-05 2010-09-07 Amgen Inc. Pharmaceutical formulations
WO2007059010A2 (en) * 2005-11-14 2007-05-24 Enterprise Partners Venture Capital Stem cell factor therapy for tissue injury
WO2007102814A2 (en) * 2006-03-07 2007-09-13 Regenetech, Inc. Recombinant mammalian molecules and method for production thereof
US8921050B2 (en) 2006-03-17 2014-12-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of diagnosing renal cell carcinoma
AU2007230902B2 (en) * 2006-03-24 2013-03-14 Children's Medical Center Corporation Method to modulate hematopoietic stem cell growth
WO2007137300A2 (en) 2006-05-23 2007-11-29 Bellicum Pharmaceuticals, Inc. Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
EP1872790A1 (en) 2006-06-26 2008-01-02 DeveloGen Aktiengesellschaft New formulation for increasing bioavailability of neurturin
EP3824885A1 (en) * 2006-10-20 2021-05-26 Children's Medical Center Corporation Method to enhance tissue regeneration
CA2691692C (en) 2007-07-09 2021-05-18 Genentech, Inc. Prevention of disulfide bond reduction during recombinant production of polypeptides
WO2009155041A2 (en) * 2008-05-28 2009-12-23 Children's Medical Center Corporation Method to modulate hematopoietic stem cell growth
EP2351599A4 (en) 2008-11-14 2013-05-08 Dnavec Corp METHOD FOR MANUFACTURING DENDRITIC CELLS
WO2010096264A2 (en) 2009-02-03 2010-08-26 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
WO2010091052A2 (en) 2009-02-03 2010-08-12 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
CN103547288B (zh) * 2011-01-10 2016-03-16 密执安大学评议会 干细胞因子抑制剂
WO2013082241A2 (en) 2011-12-02 2013-06-06 Fate Therapeutics, Inc. Improved methods of treating ischemia
WO2013082243A1 (en) 2011-12-02 2013-06-06 Fate Therapeutics, Inc. Enhanced stem cell composition
WO2014150602A1 (en) 2013-03-15 2014-09-25 Fate Therapeutics, Inc. Cell potency assay for therapeutic potential
WO2015006554A1 (en) 2013-07-10 2015-01-15 The Regents Of The University Of Michigan Therapeutic antibodies and uses thereof
US9889451B2 (en) 2013-08-16 2018-02-13 ADA-ES, Inc. Method to reduce mercury, acid gas, and particulate emissions
LT6161B (lt) 2013-09-27 2015-06-25 Uab Profarma Granuliocitų kolonijas stimuliuojančio faktoriaus sulieti baltymai su kitais augimo faktoriais, optimaliai su kamieninių ląstelių faktoriumi, ir jų gavimo būdas
JP6383216B2 (ja) * 2014-08-08 2018-08-29 シスメックス株式会社 血液分析方法、血液分析装置およびプログラム
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
CN105985424B (zh) * 2015-01-30 2019-08-23 苏州方舟生物医药有限公司 一种干细胞因子功能性肽段及其应用
CN105749252A (zh) * 2016-04-29 2016-07-13 南方医科大学 Il-9作为治疗血小板缺少症的药物的应用
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
CN108541660A (zh) * 2018-04-24 2018-09-18 上海动物园 动物饲养方法、动物饲养装置及其发酵床
CN112771162A (zh) * 2018-08-27 2021-05-07 北卡罗来纳州立大学 用剪接转换寡核苷酸靶向kit诱导肥大细胞凋亡

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695542A (en) * 1983-10-04 1987-09-22 Dnax Research Institute Of Molecular And Cellular Biology, Inc. cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity
US4810643A (en) * 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
JPS62223126A (ja) 1986-03-25 1987-10-01 Sankyo Co Ltd 血液幹細胞成長因子
US4959455A (en) 1986-07-14 1990-09-25 Genetics Institute, Inc. Primate hematopoietic growth factors IL-3 and pharmaceutical compositions
US4847325A (en) 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1

Also Published As

Publication number Publication date
CZ286303B6 (cs) 2000-03-15
SG43009A1 (en) 1997-10-17
CZ286304B6 (cs) 2000-03-15
CZ286305B6 (cs) 2000-03-15
GR3034559T3 (en) 2001-01-31
EP0992579A1 (en) 2000-04-12
CZ48897A3 (cs) 2000-01-12
CN1051937A (zh) 1991-06-05
ATE194651T1 (de) 2000-07-15
EP0992579B1 (en) 2008-08-06
SK281487B6 (sk) 2001-04-09
CZ49097A3 (cs) 2000-01-12
DE69033584T2 (de) 2001-03-08
DE69034258D1 (de) 2008-09-18
HK1010397A1 (en) 1999-06-17
EP1241258A3 (en) 2003-12-10
EP0423980B1 (en) 2000-07-12
CN1075078C (zh) 2001-11-21
EP1241258A2 (en) 2002-09-18
EP0676470A1 (en) 1995-10-11
EP0423980A1 (en) 1991-04-24
ATE403713T1 (de) 2008-08-15
SK281484B6 (sk) 2001-04-09
SK500890A3 (en) 2001-04-09
DE69033584D1 (de) 2000-08-17
SK98199A3 (en) 2001-04-09
CZ49197A3 (cs) 2000-01-12
US6218148B1 (en) 2001-04-17
US6207417B1 (en) 2001-03-27
US6207802B1 (en) 2001-03-27
CN1306007A (zh) 2001-08-01
CN1289526C (zh) 2006-12-13
SG59931A1 (en) 1999-02-22

Similar Documents

Publication Publication Date Title
DE69033584D1 (de) Stammzellenfaktor
ZA943464B (en) Vascular endothelial growth factor 2
DE68918867D1 (de) Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen.
WO1988002406A3 (en) Methods of regulating metabolic stability of proteins
DE3851153D1 (de) Genetische modifizierung von endothelialen zellen.
CA2038398A1 (en) Dna encoding a growth factor specific for epithelial cells
ATE318896T1 (de) Rekombinante rna-replikase von hepatitis-c-virus
DE69018920T2 (de) Verwendung von dns-fragmenten, die ein signalpeptid kodieren zur sekretion von reifen proteinen in rekombinanten hefen, expressions-kassetten, transformierte hefen und verfahren zur herstellung dieser proteine.
DE69428214D1 (de) Transformierender wachstumsfaktor alpha h1
EP0424416A4 (en) Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
WO2000034474A3 (en) Growth factor homolog zvegf3
HUP0002472A2 (hu) Izolált dendritikus sejtmembrán-fehérje gének
MY104910A (en) New derivatives of human/bovine4 basic fibroblast growth factor.
NO984491L (no) SCF-analogpreparater og fremgangsmÕte for fremstilling av disse
ES2004099A6 (es) Procedimiento de preparacion de polipeptidos biologicamente activos
ES8605296A1 (es) Procedimiento de producir factor viii-r humano
ZA892518B (en) Method for the in-vivo production and testing of proteins by recombinant gene expression in selected host-cells
ATE116366T1 (de) Verfahren zur herstellung eines menschlichen ''neutrophil chemotactic factor''-polypeptids.
HUP9800520A2 (hu) Génexpresszió emlős sejtekben
DE58909261D1 (de) Ancrod-proteine, ihre herstellung und verwendung.
WO1995021916A3 (en) Pp32: a newly identified cd45-associated protein
O'Donnell et al. Production of platelet-derived growth factorlike protein (s) by a human carcinoma cell line
y Mir Dissection of the medial crura as a standard procedure in rhinoplasty: case studies
TH4656EX (th) รีคอมบิแนนท์ เอนโดเธเลียล เซลล์โกรว์ธ แฟกเตอร์ของมนุษย์
NO941982L (no) Fremstilling av proteiner ved anvendelse av 7B2 protein